» Articles » PMID: 21350707

Role of the Endothelium in Inflammatory Bowel Diseases

Overview
Specialty Gastroenterology
Date 2011 Feb 26
PMID 21350707
Citations 79
Authors
Affiliations
Soon will be listed here.
Abstract

Inflammatory bowel diseases (IBD) are a complex group of diseases involving alterations in mucosal immunity and gastrointestinal physiology during both initiation and progressive phases of the disease. At the core of these alterations are endothelial cells, whose continual adjustments in structure and function coordinate vascular supply, immune cell emigration, and regulation of the tissue environment. Expansion of the endothelium in IBD (angiogenesis), mediated by inflammatory growth factors, cytokines and chemokines, is a hallmark of active gut disease and is closely related to disease severity. The endothelium in newly formed or inflamed vessels differs from that in normal vessels in the production of and response to inflammatory cytokines, growth factors, and adhesion molecules, altering coagulant capacity, barrier function and blood cell recruitment in injury. This review examines the roles of the endothelium in the initiation and propagation of IBD pathology and distinctive features of the intestinal endothelium contributing to these conditions.

Citing Articles

The Role of Immune Cells in Moyamoya Disease.

Wang S, Jiang Q, Liu Y, Zhang X, Huang Y, Zhang H Brain Sci. 2025; 15(2).

PMID: 40002470 PMC: 11852451. DOI: 10.3390/brainsci15020137.


S1PR1-biased activation drives the resolution of endothelial dysfunction-associated inflammatory diseases by maintaining endothelial integrity.

Zheng H, Yu J, Gao L, Wang K, Xu Z, Zeng Z Nat Commun. 2025; 16(1):1826.

PMID: 39979282 PMC: 11842847. DOI: 10.1038/s41467-025-57124-x.


Identification of Angiogenesis-Related Gene Signatures and Prediction of Potential Therapeutic Targets in Ulcerative Colitis Using Integrated Bioinformatics.

Xu X, Ying H, Wang X, Hong W, Zhang M J Inflamm Res. 2025; 17:11699-11717.

PMID: 39741751 PMC: 11687120. DOI: 10.2147/JIR.S478880.


Correlation between PDGF-BB and M1-type macrophage in inflammatory bowel disease: a case-control study.

Fang Z, Qu S, Ji X, Zheng C, Mo J, Xu J BMC Gastroenterol. 2024; 24(1):417.

PMID: 39567902 PMC: 11580552. DOI: 10.1186/s12876-024-03518-y.


Dynamics of Endothelial Cell Diversity and Plasticity in Health and Disease.

Larionov A, Hammer C, Fiedler K, Filgueira L Cells. 2024; 13(15.

PMID: 39120307 PMC: 11312403. DOI: 10.3390/cells13151276.


References
1.
Rafiee P, Johnson C, Li M, Ogawa H, Heidemann J, Fisher P . Cyclosporine A enhances leukocyte binding by human intestinal microvascular endothelial cells through inhibition of p38 MAPK and iNOS. Paradoxical proinflammatory effect on the microvascular endothelium. J Biol Chem. 2002; 277(38):35605-15. DOI: 10.1074/jbc.M205826200. View

2.
Binion D, Rafiee P, Ramanujam K, Fu S, Fisher P, Rivera M . Deficient iNOS in inflammatory bowel disease intestinal microvascular endothelial cells results in increased leukocyte adhesion. Free Radic Biol Med. 2000; 29(9):881-8. DOI: 10.1016/s0891-5849(00)00391-9. View

3.
Rieder F, Fiocchi C . Intestinal fibrosis in IBD--a dynamic, multifactorial process. Nat Rev Gastroenterol Hepatol. 2009; 6(4):228-35. DOI: 10.1038/nrgastro.2009.31. View

4.
Kim I, Moon S, Kim S, Kim H, Koh Y, Koh G . Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem. 2000; 276(10):7614-20. DOI: 10.1074/jbc.M009705200. View

5.
Ogawa H, Rafiee P, Heidemann J, Fisher P, Johnson N, Otterson M . Mechanisms of endotoxin tolerance in human intestinal microvascular endothelial cells. J Immunol. 2003; 170(12):5956-64. DOI: 10.4049/jimmunol.170.12.5956. View